BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, Coupland VH, Wouters MW, Lemmens VE, van de Velde CJ. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg. 2013;100:83-94. [PMID: 23180474 DOI: 10.1002/bjs.8966] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Tsuda Y, Morita M, Saeki H, Ando K, Ida S, Kimura Y, Oki E, Ohga T, Kusumoto T, Abe K, Baba S, Isoda T, Maehara Y. Esophagectomy-related thoracic duct injury detected by lymphoscintigraphy with 99mTc-diethylenetriamine pentaacetic acid-human serum albumin: report of a case. Surg Today 2015;45:517-21. [PMID: 25080863 DOI: 10.1007/s00595-014-0968-3] [Reference Citation Analysis]
2 Meng R, Bright T, Woodman RJ, Watson DI. Hospital volume versus outcome following oesophagectomy for cancer in Australia and New Zealand. ANZ Journal of Surgery 2019;89:683-8. [DOI: 10.1111/ans.15058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 O'Neill JR, Pak HS, Pairo-Castineira E, Save V, Paterson-Brown S, Nenutil R, Vojtěšek B, Overton I, Scherl A, Hupp TR. Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins. Mol Cell Proteomics 2017;16:1138-50. [PMID: 28336725 DOI: 10.1074/mcp.M116.065078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
4 Mukai Y, Kurokawa Y, Takiguchi S, Mori M, Doki Y. Are treatment outcomes in gastric cancer associated with either hospital volume or surgeon volume? Ann Gastroenterol Surg 2017;1:186-92. [PMID: 29863147 DOI: 10.1002/ags3.12031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Nelen SD, Heuthorst L, Verhoeven RHA, Polat F, Kruyt PM, Reijnders K, Ferenschild FTJ, Bonenkamp JJ, Rutter JE, de Wilt JHW, Spillenaar Bilgen EJ. Impact of Centralizing Gastric Cancer Surgery on Treatment, Morbidity, and Mortality. J Gastrointest Surg. 2017;21:2000-2008. [PMID: 28815471 DOI: 10.1007/s11605-017-3531-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
6 Gockel I, Ahlbrand CJ, Arras M, Schreiber EM, Lang H. Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery. Dig Dis Sci 2015;60:3536-44. [DOI: 10.1007/s10620-015-3790-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close!. World J Gastroenterol 2015; 21(41): 11609-11620 [PMID: 26556990 DOI: 10.3748/wjg.v21.i41.11609] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
8 van Putten M, Verhoeven RHA, van Sandick JW, Plukker JTM, Lemmens VEPP, Wijnhoven BPL, Nieuwenhuijzen GAP. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer. British Journal of Surgery 2016;103:233-41. [DOI: 10.1002/bjs.10054] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
9 Paireder M, Asari R, Kristo I, Rieder E, Zacherl J, Kabon B, Fleischmann E, Schoppmann SF. Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study. Eur Surg. 2018;50:249-255. [PMID: 30546384 DOI: 10.1007/s10353-018-0552-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Jannasch O, Kelch B, Adolf D, Tammer I, Lodes U, Weiss G, Lippert H, Mroczkowski P. Nosocomial Infections and Microbiologic Spectrum after Major Elective Surgery of the Pancreas, Liver, Stomach, and Esophagus. Surg Infect (Larchmt) 2015;16:338-45. [PMID: 26046248 DOI: 10.1089/sur.2013.248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
11 Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M; EUROCARE-5 Working Group:. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer 2015;51:2144-57. [PMID: 26421818 DOI: 10.1016/j.ejca.2015.07.026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
12 Fumagalli U, Bersani M, Russo A, Melis A, de Pascale S, Rosati R. Volume and outcomes after esophageal cancer surgery: the experience of the Region of Lombardy-Italy. Updates Surg. 2013;65:271-275. [PMID: 23943409 DOI: 10.1007/s13304-013-0227-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Visser E, Brenkman H, Verhoeven R, Ruurda J, van Hillegersberg R. Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes – A Dutch population-based cohort study. European Journal of Surgical Oncology (EJSO) 2017;43:1862-8. [DOI: 10.1016/j.ejso.2017.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
14 Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol 2016; 22(15): 4041-4048 [PMID: 27099448 DOI: 10.3748/wjg.v22.i15.4041] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
15 Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D;  ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Cited by in Crossref: 609] [Cited by in F6Publishing: 563] [Article Influence: 101.5] [Reference Citation Analysis]
16 Lagergren J, Mattsson F, Lagergren P. Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis. Ann Surg 2016;263:1133-7. [PMID: 26565140 DOI: 10.1097/SLA.0000000000001324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
17 Naredi P, La Quaglia MP. The future of trials in surgical oncology. Nat Rev Clin Oncol 2015;12:425-31. [DOI: 10.1038/nrclinonc.2015.72] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
18 Kjaer DW, Nassar M, Jensen LS, Svendsen LB, Mortensen FV. A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database. Dis Esophagus 2017;30:1-7. [PMID: 27001181 DOI: 10.1111/dote.12474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE. Is It Time to Centralize High-risk Cancer Care in the United States? Comparison of Outcomes of Esophagectomy Between England and the United States. Ann Surg. 2015;262:79-85. [PMID: 24979602 DOI: 10.1097/sla.0000000000000805] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 8.6] [Reference Citation Analysis]
20 Clavien P. Targeting Quality in Surgery. Annals of Surgery 2013;258:659-68. [DOI: 10.1097/sla.0b013e3182a61965] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
21 Mahar AL, El-Sedfy A, Dixon M, Siddiqui M, Elmi M, Ritter A, Vasilevska-Ristovska J, Jeong Y, Helyer L, Law C, Zagorski B, Coburn NG. Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario. Curr Oncol 2018;25:e436-43. [PMID: 30464695 DOI: 10.3747/co.25.3953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Voeten DM, van der Werf LR, Wilschut JA, Busweiler LAD, van Sandick JW, van Hillegersberg R, van Berge Henegouwen MI; Dutch Upper Gastrointestinal Cancer Audit Group. Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study. Ann Surg Oncol 2021;28:4484-96. [PMID: 33486644 DOI: 10.1245/s10434-020-09510-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Busweiler LAD, Wijnhoven BPL, van Berge Henegouwen MI, Henneman D, van Grieken NCT, Wouters MWJM, van Hillegersberg R, van Sandick JW, Bosscha K, Cats A, Dikken JL, Hartgrink HH, Jong PC, Lemmens VEPP, Nieuwenhuijzen GAP, Plukker JT, Rosman C, Rozema T, Siersema PD, Tetteroo G, Veldhuis PMJF, Voncken FEM. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. British Journal of Surgery 2016;103:1855-63. [DOI: 10.1002/bjs.10303] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
24 Messager M, de Steur WO, van Sandick JW, Reynolds J, Pera M, Mariette C, Hardwick RH, Bastiaannet E, Boelens PG, van deVelde CJ, Allum WH; EURECCA Upper GI Group. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol. 2016;42:116-122. [PMID: 26461256 DOI: 10.1016/j.ejso.2015.09.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
25 Priego P, Cuadrado M, Ballestero A, Galindo J, Lobo E. Comparison of Laparoscopic Versus Open Gastrectomy for Treatment of Gastric Cancer: Analysis of a Textbook Outcome. Journal of Laparoendoscopic & Advanced Surgical Techniques 2019;29:458-64. [DOI: 10.1089/lap.2018.0489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
26 Mokart D, Giaoui E, Barbier L, Lambert J, Sannini A, Chow-Chine L, Brun JP, Faucher M, Guiramand J, Ewald J. Postoperative sepsis in cancer patients undergoing major elective digestive surgery is associated with increased long-term mortality. J Crit Care. 2016;31:48-53. [PMID: 26507291 DOI: 10.1016/j.jcrc.2015.10.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
27 Tweed T, van Eijden Y, Tegels J, Brenkman H, Ruurda J, van Hillegersberg R, Sosef M, Stoot J. Safety and efficacy of early oral feeding for enhanced recovery following gastrectomy for gastric cancer: A systematic review. Surg Oncol 2019;28:88-95. [PMID: 30851919 DOI: 10.1016/j.suronc.2018.11.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
28 Rasmussen SR, Nielsen RV, Fenger AS, Siemsen M, Ravn HB. Postoperative complications and survival after surgical resection of esophageal squamous cell carcinoma. J Thorac Dis 2018;10:4052-60. [PMID: 30174848 DOI: 10.21037/jtd.2018.07.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Davis SS, Noll D, Patel P, Maloney RT, Maddern GJ. Gastrectomy mortality in Australia. ANZ J Surg 2022. [PMID: 35180327 DOI: 10.1111/ans.17540] [Reference Citation Analysis]
30 Gupta V, Levy J, Allen-Ayodabo C, Amirazodi E, Davis L, Li Q, Mahar A, Coburn NG; PRESTO Study Investigators. Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO): protocol for a multicentre clinical and pathological database including 25 000 patients. BMJ Open 2020;10:e032729. [PMID: 32474423 DOI: 10.1136/bmjopen-2019-032729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 van der Kaaij RT, Koemans WJ, van Putten M, Snaebjornsson P, Luijten JCHBM, van Dieren JM, Cats A, Lemmens VEPP, Verhoeven RHA, van Sandick JW. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer 2020;130:23-31. [PMID: 32171106 DOI: 10.1016/j.ejca.2020.02.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
32 Escrig J, Mingol F, Martí R, Puche J, Trullenque R, Barreras JA, Asencio F, Aguiló J, Navarro JM, Alberich C, Salas D, Lacueva FJ. Resultados iniciales del registro de carcinomas esófago-gástricos de la Comunidad Valenciana. Cirugía Española 2017;95:428-36. [DOI: 10.1016/j.ciresp.2017.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Burton PR, Ooi GJ, Shaw K, Smith AI, Brown WA, Nottle PD. Assessing quality of care in oesophago-gastric cancer surgery in Australia: Quality in oesophago-gastric cancer. ANZ Journal of Surgery 2018;88:290-5. [DOI: 10.1111/ans.13752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
34 Keong B, Cade R, Mackay S. Post-oesophagectomy mortality: the centralization debate revisited. ANZ J Surg 2016;86:116-7. [DOI: 10.1111/ans.13357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Wilson EE, Thompson SK, Bull J, Jones B, Price T, Devitt PG, Watson DI, Bright T. Improving care for patients with oesophageal and gastric cancer: impact of a statewide multidisciplinary team: Statewide upper GI cancer MDT. ANZ J Surg 2016;86:270-3. [DOI: 10.1111/ans.12869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Seeruttun SR, Xu L, Wang F, Yi X, Fang C, Liu Z, Wang W, Zhou Z. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes. Cancer Commun (Lond) 2019;39:32. [PMID: 31182160 DOI: 10.1186/s40880-019-0370-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Koëter M, van Steenbergen LN, Lemmens VE, Rutten HJ, Roukema JA, Wijnhoven BP, Nieuwenhuijzen GA. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer. Eur J Surg Oncol 2014;40:1338-45. [PMID: 24484779 DOI: 10.1016/j.ejso.2013.12.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
38 Brenkman HJF, Visser E, van Rossum PSN, Siesling S, van Hillegersberg R, Ruurda JP. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands. Ann Surg Oncol 2017;24:1761-9. [PMID: 28353020 DOI: 10.1245/s10434-017-5820-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
39 Speelman AD, van Gestel YRBM, Rutten HJT, de Hingh IHJT, Lemmens VEPP. Changes in gastrointestinal cancer resection rates. British Journal of Surgery 2015;102:1114-22. [DOI: 10.1002/bjs.9862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
40 Stillman MD, Yoon SS. Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes. J Surg Oncol 2022. [PMID: 35416303 DOI: 10.1002/jso.26887] [Reference Citation Analysis]
41 Xing XZ, Wang HJ, Qu SN, Huang CL, Zhang H, Wang H, Yang QH, Gao Y. The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy. J Thorac Dis 2016;8:1780-7. [PMID: 27499969 DOI: 10.21037/jtd.2016.06.28] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 7.2] [Reference Citation Analysis]
42 Busweiler LAD, Jeremiasen M, Wijnhoven BPL, Lindblad M, Lundell L, van de Velde CJH, Tollenaar RAEM, Wouters MWJM, van Sandick JW, Johansson J, Dikken JL. International benchmarking in oesophageal and gastric cancer surgery. BJS Open 2019;3:62-73. [PMID: 30734017 DOI: 10.1002/bjs5.50107] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Kung CH, Jestin Hannan C, Linder G, Johansson J, Nilsson M, Hedberg J, Lindblad M. Impact of surgical resection rate on survival in gastric cancer: nationwide study. BJS Open 2021;5:zraa017. [PMID: 33688944 DOI: 10.1093/bjsopen/zraa017] [Reference Citation Analysis]
44 Erdem S, Troxler E, Warschkow R, Tsai C, Yerokun B, Schmied B, Stettler C, Blazer DG 3rd, Hartwig M, Worni M, Gloor B. Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus?Ann Surg Oncol. 2020;27:671-680. [PMID: 31605338 DOI: 10.1245/s10434-019-07847-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Kjaer DW, Larsson H, Svendsen LB, Jensen LS. Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013. British Journal of Surgery 2017;104:1338-45. [DOI: 10.1002/bjs.10586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
46 Giacopuzzi S, Bencivenga M, Cipollari C, Weindelmayer J, de Manzoni G. Lymphadenectomy: how to do it? Transl Gastroenterol Hepatol 2017;2:28. [PMID: 28447063 DOI: 10.21037/tgh.2017.03.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
47 Davis SS, Babidge WJ, Kiermeier A, Maddern GJ. Regional versus metropolitan pancreaticoduodenectomy mortality in Australia. ANZ Journal of Surgery 2018;89:1582-6. [DOI: 10.1111/ans.15336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
48 Shrikhande SV, Pai E. Enhanced recovery after surgery in laparoscopic gastric cancer surgery: Many questions, few answers. J Minim Access Surg 2014;10:105-6. [PMID: 25013324 DOI: 10.4103/0972-9941.134871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Gao Z, Deng G, Li Y, Huang H, Sun X, Shi H, Yao X, Gao L, Ju Y, Luo M. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression. Biomed Pharmacother 2020;126:110092. [PMID: 32203890 DOI: 10.1016/j.biopha.2020.110092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
50 Narendra A, Baade PD, Aitken JF, Fawcett J, Smithers BM. Impact of hospital resection volume and service capability on post‐operative mortality following gastrectomy. ANZ Journal of Surgery 2019;90:86-91. [DOI: 10.1111/ans.15616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Helminen O, Sihvo E, Gunn J, Sipilä JOT, Rautava P, Kytö V. Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014. European Journal of Cardio-Thoracic Surgery 2020;57:107-13. [DOI: 10.1093/ejcts/ezz189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Téoule P, Birgin E, Mertens C, Schwarzbach M, Post S, Rahbari NN, Reißfelder C, Ronellenfitsch U. Clinical Pathways for Oncological Gastrectomy: Are They a Suitable Instrument for Process Standardization to Improve Process and Outcome Quality for Patients Undergoing Gastrectomy? A Retrospective Cohort Study. Cancers (Basel) 2020;12:E434. [PMID: 32069805 DOI: 10.3390/cancers12020434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Brenkman HJF, Ruurda JP, Verhoeven RHA, van Hillegersberg R. Safety and feasibility of minimally invasive gastrectomy during the early introduction in the Netherlands: short-term oncological outcomes comparable to open gastrectomy. Gastric Cancer 2017;20:853-60. [PMID: 28185027 DOI: 10.1007/s10120-017-0695-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
54 Bencivenga M, Verlato G, Mengardo V, Weindelmayer J, Allum WH. Do all the European surgeons perform the same D2? The need of D2 audit in Europe. Updates Surg 2018;70:189-95. [PMID: 29869322 DOI: 10.1007/s13304-018-0542-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tegels JJ, Stoot JH. Way forward: Geriatric frailty assessment as risk predictor in gastric cancer surgery. World J Gastrointest Surg 2015; 7(10): 223-225 [PMID: 26523209 DOI: 10.4240/wjgs.v7.i10.223] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
56 Maharaj AD, Holland JF, Scarborough RO, Evans SM, Ioannou LJ, Brown W, Croagh DG, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong CP, Evans P, Goldstein D, Haydon A, Hii MW, Knowles BPF, Merrett ND, Michael M, Neale RE, Philip J, Porter IWT, Smith M, Spillane J, Tagkalidis PP, Zalcberg JR. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. BMJ Open 2019;9:e031434. [PMID: 31575580 DOI: 10.1136/bmjopen-2019-031434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Linder G, Lindblad M, Djerf P, Elbe P, Johansson J, Lundell L, Hedberg J. Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer. British Journal of Surgery 2016;103:1326-35. [DOI: 10.1002/bjs.10234] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
58 Jeremiasen M, Linder G, Hedberg J, Lundell L, Björ O, Lindblad M, Johansson J. Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007-2016 from a national quality register. Dis Esophagus 2020;33:doz070. [PMID: 31608927 DOI: 10.1093/dote/doz070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
59 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Radiotherapy and Oncology 2014;110:189-94. [DOI: 10.1016/j.radonc.2013.09.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
60 Osorio J, Rodríguez-santiago J, Roig J, Pera M. Proyectos de estandarización del tratamiento del cáncer de la unión esofagogástrica: centralización, registros y formación. Cirugía Española 2019;97:470-6. [DOI: 10.1016/j.ciresp.2019.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Terazawa T, Matsuyama J, Goto M, Kawabata R, Endo S, Imano M, Fujita S, Akamaru Y, Taniguchi H, Tatsumi M, Lee SW, Kurisu Y, Kawakami H, Kurokawa Y, Shimokawa T, Sakai D, Kato T, Fujitani K, Satoh T. A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601). Oncologist 2020;25:119-e208. [PMID: 32043772 DOI: 10.1634/theoncologist.2019-0601] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: a clinical practice guideline. Curr Oncol 2017;24:324-31. [PMID: 29089800 DOI: 10.3747/co.24.3736] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
63 Davis SS, Babidge WJ, Kiermeier A, Aitken RJ, Maddern GJ. Perioperative Mortality Following Oesophagectomy and Pancreaticoduodenectomy in Australia. World J Surg 2018;42:742-8. [DOI: 10.1007/s00268-017-4204-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
64 Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: A systematic review. Cancer Treatment Reviews 2018;63:104-15. [DOI: 10.1016/j.ctrv.2017.12.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 10.5] [Reference Citation Analysis]
65 Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-648. [PMID: 32861308 DOI: 10.1016/s0140-6736(20)31288-5] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 81.0] [Reference Citation Analysis]
66 Helminen O, Mrena J, Sihvo E. Can We Increase the Resection Rate by Minimally Invasive Approach? Experience from 100 Minimally Invasive Esophagectomies. J Oncol 2019;2019:3809383. [PMID: 30915119 DOI: 10.1155/2019/3809383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
67 van de Velde CJ. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer (Br J Surg 2014; 101: 23-31). Br J Surg. 2014;101:31-32. [PMID: 24375297 DOI: 10.1002/bjs.9380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
68 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO)., European Society of Surgical Oncology (ESSO)., European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi57-63. [PMID: 24078663 DOI: 10.1093/annonc/mdt344] [Cited by in Crossref: 179] [Cited by in F6Publishing: 177] [Article Influence: 22.4] [Reference Citation Analysis]
69 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
70 Herbella FAM, Laurino Neto RM, Allaix ME, Patti MG. Extended Lymphadenectomy in Esophageal Cancer is Debatable. World J Surg 2013;37:1757-67. [DOI: 10.1007/s00268-013-2018-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
71 Markar SR, Low DE. The Volume-Outcome Relationship, Standardized Clinical Pathways, and Minimally Invasive Surgery for Esophagectomy. In: Hochwald SN, Kukar M, editors. Minimally Invasive Foregut Surgery for Malignancy. Cham: Springer International Publishing; 2015. pp. 25-34. [DOI: 10.1007/978-3-319-09342-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Peppelenbosch MP, Spaander MCW, Bruno MJ. Glutathione peroxidase 7 prevents cancer in the oesophagus. Gut 2014;63:537-8. [DOI: 10.1136/gutjnl-2013-304906] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
73 Kamarajah SK, Markar SR, Phillips AW, Salti GI, Dahdaleh FS. Local Endoscopic Resection is Inferior to Gastrectomy for Early Clinical Stage T1a and T1b Gastric Adenocarcinoma: A Propensity-Matched Study. Ann Surg Oncol 2021;28:2992-8. [PMID: 33452601 DOI: 10.1245/s10434-020-09485-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Koëter M, Parry K, Verhoeven RHA, Luyer MDP, Ruurda JP, van Hillegersberg R, Lemmens VEPP, Nieuwenhuijzen GAP. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands. Ann Surg Oncol 2016;23:1632-8. [DOI: 10.1245/s10434-015-5061-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
75 Bencivenga M, Torroni L, Verlato G, Mengardo V, Sacco M, Allum WH, de Manzoni G. Lymphadenectomy for gastric cancer at European specialist centres. Eur J Surg Oncol 2021;47:1048-54. [PMID: 33092970 DOI: 10.1016/j.ejso.2020.10.013] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Iwatsuki M, Yamamoto H, Miyata H, Kakeji Y, Yoshida K, Konno H, Seto Y, Baba H. Effect of hospital and surgeon volume on postoperative outcomes after distal gastrectomy for gastric cancer based on data from 145,523 Japanese patients collected from a nationwide web-based data entry system. Gastric Cancer 2019;22:190-201. [DOI: 10.1007/s10120-018-0883-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
77 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:584-591. [PMID: 24685156 DOI: 10.1016/j.ejso.2013.09.020] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 12.9] [Reference Citation Analysis]
78 Emilsson L, Lindahl B, Köster M, Lambe M, Ludvigsson JF. Review of 103 Swedish Healthcare Quality Registries. J Intern Med 2015;277:94-136. [DOI: 10.1111/joim.12303] [Cited by in Crossref: 197] [Cited by in F6Publishing: 190] [Article Influence: 24.6] [Reference Citation Analysis]
79 Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301 [PMID: 26715812 DOI: 10.3748/wjg.v21.i47.13294] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
80 Däster S, Soysal SD, Koechlin L, Stoll L, Peterli R, von Flüe M, Ackermann C. Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization. Langenbecks Arch Surg 2016;401:787-95. [DOI: 10.1007/s00423-016-1477-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
81 Tegels JJ, De Maat MF, Hulsewé KW, Hoofwijk AG, Stoot JH. Improving the outcomes in gastric cancer surgery. World J Gastroenterol 2014; 20(38): 13692-13704 [PMID: 25320507 DOI: 10.3748/wjg.v20.i38.13692] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
82 Voeten DM, Gisbertz SS, Ruurda JP, Wilschut JA, Ferri LE, van Hillegersberg R, van Berge Henegouwen MI; Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group. Overall Volume Trends in Esophageal Cancer Surgery Results From the Dutch Upper Gastrointestinal Cancer Audit. Ann Surg 2021;274:449-58. [PMID: 34397452 DOI: 10.1097/SLA.0000000000004985] [Reference Citation Analysis]
83 Findlay JM, Tilson RC, Harikrishnan A, Sgromo B, Marshall REK, Maynard ND, Gillies RS, Middleton MR. Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications: Attempted validation of the NUn score. Dis Esophagus 2015;28:626-33. [DOI: 10.1111/dote.12244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
84 Henneman D, ten Berge MG, Snijders HS, van Leersum NJ, Fiocco M, Wiggers T, Tollenaar RA, Wouters MW; on behalf of the Dutch Surgical Colorectal Audit Group. Safety of elective colorectal cancer surgery: Non-surgical complications and colectomies are targets for quality improvement: Targets for Quality Improvement. J Surg Oncol 2014;109:567-73. [DOI: 10.1002/jso.23532] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
85 Resanovic A, Randjelovic T, Resanovic V, Toskovic B. Double Tract vs. Roux-en-Y Reconstruction in the treatment of Gastric Cancer. Pak J Med Sci 2018;34:643-8. [PMID: 30034431 DOI: 10.12669/pjms.343.14348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 Rochigneux P, Resbeut M, Rousseau F, Bories E, Raoul JL, Poizat F, Moureau-Zabotto L. Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients. Front Oncol 2014;4:100. [PMID: 24860783 DOI: 10.3389/fonc.2014.00100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
87 Rihuete-Caro C, Pereira-Pérez F, Manzanedo-Romero I, Carrión-Álvarez L. Internal audit of oncological results in gastric cancer surgery. Cir Esp (Engl Ed) 2021:S0009-739X(21)00026-9. [PMID: 33581842 DOI: 10.1016/j.ciresp.2021.01.005] [Reference Citation Analysis]
88 van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, Stoot JHMB, Tegels JJW, Wijnhoven BPL, Lagarde SM, de Steur WO, Hartgrink HH, Kouwenhoven EA, Wassenaar EB, Draaisma WA, Gisbertz SS, van der Peet DL, May AM, Ruurda JP, van Hillegersberg R; LOGICA Study Group. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol 2021;39:978-89. [PMID: 34581617 DOI: 10.1200/JCO.20.01540] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
89 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
90 Busweiler LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, de Jong PC, Rozema T, Wijnhoven BP, van Hillegersberg R, Wouters MW, van Sandick JW; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group. Textbook outcome as a composite measure in oesophagogastric cancer surgery. Br J Surg 2017;104:742-50. [PMID: 28240357 DOI: 10.1002/bjs.10486] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
91 Uslu A, Zengel B, İlhan E, Aykas A, Şimşek C, Üreyen O, Duran A, Okut G. Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center. Turk J Surg 2018;34:125-30. [PMID: 30023977 DOI: 10.5152/turkjsurg.2018.3846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A. Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev. 2014;40:692-700. [PMID: 24656602 DOI: 10.1016/j.ctrv.2014.03.002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 14.6] [Reference Citation Analysis]
93 Dijksterhuis WPM, Verhoeven RHA, Meijer SL, Slingerland M, Haj Mohammad N, de Vos-Geelen J, Beerepoot LV, van Voorthuizen T, Creemers GJ, van Oijen MGH, van Laarhoven HWM. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study. Gastric Cancer 2020;23:579-90. [PMID: 31927675 DOI: 10.1007/s10120-020-01039-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
94 Smith RC, Creighton N, Lord RV, Merrett ND, Keogh GW, Liauw WS, Currow DC. Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001–2008. Medical Journal of Australia 2014;200:408-13. [DOI: 10.5694/mja13.11182] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
95 Dijksterhuis WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, de Vos-Geelen J, Beerepoot LV, van Voorthuizen T, Creemers GJ, van Oijen MGH, van Laarhoven HWM. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study. Int J Cancer. 2020;146:1889-1901. [PMID: 31340065 DOI: 10.1002/ijc.32580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
96 Liao XL, Liang XW, Pang HY, Yang K, Chen XZ, Chen XL, Liu K, Zhao LY, Zhang WH, Hu JK. Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis. Front Oncol 2021;11:704244. [PMID: 34422658 DOI: 10.3389/fonc.2021.704244] [Reference Citation Analysis]
97 Busweiler L, Henneman D, Dikken J, Fiocco M, van Berge Henegouwen M, Wijnhoven B, van Hillegersberg R, Rosman C, Wouters M, van Sandick J, Bosscha K, Cats A, van Grieken N, Hartgrink H, Lemmens V, Nieuwenhuijzen G, Plukker J, Siersema P, Tetteroo G, Veldhuis P, Voncken F. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer. European Journal of Surgical Oncology (EJSO) 2017;43:1962-9. [DOI: 10.1016/j.ejso.2017.07.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
98 Paireder M, Jomrich G, Asari R, Kristo I, Gleiss A, Preusser M, Schoppmann SF. External validation of the NUn score for predicting anastomotic leakage after oesophageal resection. Sci Rep 2017;7:9725. [PMID: 28852063 DOI: 10.1038/s41598-017-10084-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
99 Huang L, Jansen L, Balavarca Y, Verhoeven RHA, Ruurda JP, Van Eycken L, De Schutter H, Johansson J, Lindblad M, Johannesen TB, Zadnik V, Žagar T, Mägi M, Bastiaannet E, Lagarde SM, van de Velde CJH, Schrotz-King P, Brenner H. Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States. Clin Transl Med 2020;10:e203. [PMID: 33135354 DOI: 10.1002/ctm2.203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ptok H, Gastinger I, Meyer F, Ilsemann A, Lippert H, Bruns C. [Hospital volume effects in surgical treatment of gastric cancer : Results of a prospective multicenter observational study]. Chirurg 2017;88:328-38. [PMID: 27678401 DOI: 10.1007/s00104-016-0292-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
101 de Mestier L, Lardière-Deguelte S, Volet J, Kianmanesh R, Bouché O. Recent insights in the therapeutic management of patients with gastric cancer. Dig Liver Dis. 2016;48:984-994. [PMID: 27156069 DOI: 10.1016/j.dld.2016.04.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
102 Tegels JJ, Silvius CE, Spauwen FE, Hulsewé KW, Hoofwijk AG, Stoot JH. Introduction of laparoscopic gastrectomy for gastric cancer in a Western tertiary referral centre: A prospective cost analysis during the learning curve. World J Gastrointest Oncol 2017; 9(5): 228-234 [PMID: 28567187 DOI: 10.4251/wjgo.v9.i5.228] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Galata C, Ronellenfitsch U, Blank S, Reißfelder C, Hardt J. Postoperative Morbidity and Failure to Rescue in Surgery for Gastric Cancer: A Single Center Retrospective Cohort Study of 1107 Patients from 1972 to 2014. Cancers (Basel) 2020;12:E1953. [PMID: 32708438 DOI: 10.3390/cancers12071953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Haverkamp L, Seesing MF, Ruurda JP, Boone J, V Hillegersberg R. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus. 2017;30:1-7. [PMID: 27001442 DOI: 10.1111/dote.12480] [Cited by in Crossref: 22] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
105 Ezzy M, Heinz P, Kraus TW, Elshafei M. Incarcerated hiatal hernia - A rare postoperative complication following gastrectomy for stomach cancer. A case report and literature review. Int J Surg Case Rep 2021;79:219-21. [PMID: 33485169 DOI: 10.1016/j.ijscr.2021.01.046] [Reference Citation Analysis]
106 Glatz T, Höppner J. Is There a Rationale for Structural Quality Assurance in Esophageal Surgery? Visc Med 2017;33:135-9. [PMID: 28560229 DOI: 10.1159/000458454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]